WHYUS
We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
NewsEvents
18 February 2019
March 4-6, Tokyo, Japan
Meet Heidi Kingdon-Jones, our Global VP of Sales and Marketing, at BioAsia from March 4 to March 6! To learn more about how IRBM’s capabilities and how we can support and accelerate your drug discovery programs.
Meet Heidi Kingdon-Jones, our Global VP of Sales and Marketing, at BioAsia from March 4 to March 6! To learn more about how IRBM’s capabilities and how we can support and accelerate your drug discovery programs.
AsiaTides
18 February 2019
February 26-28, Tokyo, Japan.
If you are attending AsiaTides from February 26 to February 28, take the opportunity to meet with Heidi Kingdon-Jones and Dr. Raffaele Ingenito, and learn more about how IRBM can support your drug discovery program.
If you are attending AsiaTides from February 26 to February 28, take the opportunity to meet with Heidi Kingdon-Jones and Dr. Raffaele Ingenito, and learn more about how IRBM can support your drug discovery program.
CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics
19 November 2018
Pomezia, Italy, November 19th 2018 – IRBM, a global contract research organization (CRO), has strengthened its position in neurodegenerative disease…
BIO-Europe 2018
5 November 2018
November 5-7, 2018 Copenhagen, Denmark Come meet IRBM’s delegates in Copenhagen to learn more about how IRBM can support your…